Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations
Several studies highlight a key involvement of endocannabinoid (EC) system in autism pathophysiology. The EC system is a complex network of lipid signaling pathways comprised of arachidonic acid-derived compounds (anandamide, AEA) and 2-arachidonoyl glycerol (2-AG), their G-protein-coupled receptors...
Main Authors: | Anna Lisa Brigida, Stephen Schultz, Mariana Cascone, Nicola Antonucci, Dario Siniscalco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/7/1425 |
Similar Items
-
Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders
by: Dario Siniscalco, et al.
Published: (2018-06-01) -
Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
by: Stephen Schultz, et al.
Published: (2021-03-01) -
Endocannabinoid system involvement in autism spectrum disorder: An overview with potential therapeutic applications
by: Stephen Schultz, et al.
Published: (2019-05-01) -
Novel frontiers in autism discovery:a commentary on: The impact of neuroimmune alterations in autism spectrum disorder
by: Dario eSiniscalco
Published: (2015-10-01) -
Autism and neuro-immune-gut link
by: Dario Siniscalco, et al.
Published: (2018-06-01)